A carregar...
Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis
OBJECTIVE: To integrate long-term measures of disease-modifying drug efficacy and risk to guide selection of first-line treatment of multiple sclerosis. METHODS: We created a Markov decision model to evaluate disability worsening and progressive multifocal leukoencephalopathy (PML) risk in patients...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5317380/ https://ncbi.nlm.nih.gov/pubmed/28087821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003612 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|